Nicole Shonka is an Oncology physician affiliated with Fred and Pamela Buffett Cancer Center. OpenAlex indexes 195 publications with 3,139 citations (h-index 21); ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
988102 Nebraska Medical Ctr
Omaha, NE 681988102
Telephone
402-559-9800Registry record last updated 18 Dec 2013.
Clinical trials
- A Study of ONC201 for Refractory Meningioma
Sponsor: University of Nebraska
- Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab
Sponsor: Aveta Biomics, Inc.
- A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
Sponsor: University of Nebraska
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- JAZZ PHARMACEUTICALS INC.Program year20252 payments
- SERVIER PHARMACEUTICALS LLCProgram year20251 payment
- Novocure Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2022–2025 per NIH RePORTER. The latest:
- Connectivity mapping identified novel combination therapy for glioblastoma
University of Nebraska Medical Center
FY2025$891,835R01CA273319 - Connectivity mapping identified novel combination therapy for glioblastoma
University of Nebraska Medical Center
FY2024$423,622R01CA273319 - Connectivity mapping identified novel combination therapy for glioblastoma
University of Nebraska Medical Center
FY2023$436,999R01CA273319
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Anthony Hollingsworth
Fred and Pamela Buffett Cancer Center
Rudy Lackner, MD
Fred and Pamela Buffett Cancer Center
Benjamin Teply, MD
Fred and Pamela Buffett Cancer Center
Weining Zhen, MD
Fred and Pamela Buffett Cancer Center
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”